跳至主要内容
临床试验/NCT05155553
NCT05155553已完成不适用

An Observational Clinical Performance Evaluation Study Testing Residual Specimens of Cerebrospinal Fluid Obtained by Lumbar Puncture From Meningitis/Encephalitis Subjects Using the QIAstat-Dx® Meningitis/Encephalitis Panel

QIAGEN Gaithersburg, Inc1 个研究点 分布在 1 个国家目标入组 1,524 人开始时间: 2022年5月4日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
1,524
试验地点
1
主要终点
PPA

研究概览

简要总结

Study for performance evaluation of the QIAstat-Dx® Meningitis/Encephalitis Panel in comparison with other chosen comparator methods.

详细描述

This multicenter study aims to evaluate the performance of QIAstat-Dx Meningitis/Encephalitis (ME) Panel with another validated comparator method.

研究设计

研究类型
Observational
观察模型
Other
时间视角
Prospective

入排标准

性别
All
接受健康志愿者

入选标准

  • Residual specimens (minimum 500μL) of CSF obtained by lumbar puncture from subjects with signs and symptoms of meningitis and/or encephalitis following completion of routine testing Specimen that have not undergone more than 3 freeze/thaw cycles.

排除标准

  • Specimens not fitting criteria outlined above.
  • CSF obtained from an external ventricular drain or shunt source.
  • Lack of clear subject identification or label on residual banked CSF specimen.
  • Specimen has been centrifuged.
  • Obvious physical damage of banked residual specimen.
  • Repeat specimens from the same subject.

结局指标

主要结局

PPA

时间窗: 6 months

positive percentage agreement

NPA

时间窗: 6 months

negative percentage agreement

次要结局

未报告次要终点

研究者

发起方
QIAGEN Gaithersburg, Inc
申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验